- Anibal Brullo, CFO, Drogueria del Sud S.A.
- Carlos Moreira, Pharma & Life Sciences Technology Leader, PwC
- Abraham Okore, Managing Director, Pyramid Healthcare Limited
- Prashant Tandon, Co-Founder & CEO, 1mg
- Subir Basak, Senior Industry Specialist, IFC
Pharmaceuticals is a $1.4 trillion global industry, covering products and services. One sector expert and three pharmaceutical suppliers, each operating in a different region, described their markets and discussed the challenges and solutions associated with so-called last mile connectivity—the process of bringing pharmaceuticals to the patients.
Abraham Okore, Managing Director of Pyramid Healthcare Limited, a supplier of medicines and medical devices with operations in 15 African countries, Tanzania being its biggest hub, noted that most of their patients live in rural areas, which creates huge challenges in terms reach. “Patients are having to walk several kilometers before they can access services in most of the countries,” noted Okore. Pyramid works with philanthropic organizations such as the Gates Foundation to improve access to medicines. Anibal Brullo, the CFO of Drogueria del Sud S.A., one of the largest pharmaceutical wholesalers and distributors in Argentina, said that there were over 230 labs in the country, most of whom are affiliated with four big pharmaceutical distributor groups that have a 90 percent market share between them. In addition, there are more than a thousand drug wholesalers and 13,000 pharmacies in Argentina.